Institute for Cancer Research
Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.
The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.
Scientific production - Institute for Cancer Research
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".
For the month of June 2014, this honour went to Karin Cecilie Lødrup Carlsen from the Department of Paediatric Medicine at the Women and Children's Division, Oslo University Hospital.
Professors Ragnhild A. Lothe, Guro E. Lind and Rolf Skotheim recently arranged a popular science event for the inhabitants of Røst with support from the mayor of Røst, Tor Andreassen, and the district medical officer, Kjell Arne Helgebostad.
Anne-Lise Børresen-Dale, head of the Department of Genetics at the Insitute for Cancer Research, has recently been selected for the The Helmholtz International Fellow Award For Excellent Researchers and Science Managers and is welcomed as an honorary member into the Helmholtz community.
Cooperation with the world's best researchers is a key objective of the Helmholtz Association's international activities. To this end, the organisation established the Helmholtz International Fellow Award in 2012, which targets outstanding senior scientists and research managers based outside Germany who have excelled in fields relevant to the Helmholtz Association, including science management at large international research institutions.
King Olav V's cancer research prize for 2014 was on June 2nd given to professor Harald A. Stenmark from the Department of Biochemistry at the Divison of Cancer Medicine, Surgery and Transplantation, OUS.
The prestigious prize is distributed annually by the Norwegian Cancer Society, and the winner receives NOK 1.000.000.
The South-East Norway regional health authority, Helse Sør-Øst RHF, in collaboration with the University of Oslo now invites applications for research funding for 2015.
The total funds available amount to approximately 100 million NOKs to be granted to new research projects and research activities in 2015.
The application deadline is September 5th 2014, 4:00 PM.
Jul 21, 2014
Jul 2, 2014
Jun 17, 2014
Inst. for Cancer Research
Why less is more when generating tryptic peptides in bottom-up proteomics
Proteomics (in press)
Minimal and maximal incidence rates of skin cancer in Caucasians estimated by use of sigmoidal UV dose-incidence curves
Int J Hyg Environ Health (in press)
Journal Impact Factor > 5, first or last author from the Institute for Cancer Research
RNA-seq permits a closer look at normal skin and psoriasis gene networks
J Invest Dermatol, 134 (7), 1789-91